Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

"Unintelligible" allegations in a class action supported by Clive Palmer over claimed COVID-19 vaccine injuries have been ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). These two vaccine ...